Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Eman T. Mehanna, Noha M. Mesbah, Maivel H. Ghattas, Samy M. Saleh & Dina M. Abo-Elmatty. (2016) Association of chemerin Rs17173608 and vaspin Rs2236242 gene polymorphisms with metabolic syndrome in Egyptian women. Endocrine Research 41:1, pages 43-48.
Read now
Read now
Joanna Blaszak, Marek Szolkiewicz, Elzbieta Sucajtys-Szulc, Marcin Konarzewski, Slawomir Lizakowski, Julian Swierczynski & Boleslaw Rutkowski. (2015) High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction. Renal Failure 37:6, pages 1033-1038.
Read now
Read now
Sayer I Al-Azzam, Karem H Alzoubi, Jaafar Abu Abeeleh, Nizar M Mhaidat & Mahmoud Abu-Abeeleh. (2013) Effect of statin therapy on vaspin levels in type 2 diabetic patients. Clinical Pharmacology: Advances and Applications 5, pages 33-38.
Read now
Read now
Mika Venojärvi, Niko Wasenius, Sirpa Manderoos, Olli J. Heinonen, Miika Hernelahti, Harri Lindholm, Jukka Surakka, Jaana Lindström, Sirkka Aunola, Mustafa Atalay & Johan G. Eriksson. (2013) Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Annals of Medicine 45:2, pages 162-170.
Read now
Read now
Michał Kukla, Agnieszka Berdowska, Dominika Stygar, Andrzej Gabriel, Włodzimierz Mazur, Beata Łogiewa-Bazger, Barbara Sobala-Szczygieł, Rafał J Bułdak, Maria Rokitka, Wojciech Zajęcki, Lucjan Kępa, Tomasz Sawczyn & Krystyna Żwirska-Korczala. (2012) Serum FGF21 and RBP4 levels in patients with chronic hepatitis C. Scandinavian Journal of Gastroenterology 47:8-9, pages 1037-1047.
Read now
Read now
Halil Genc, Teoman Dogru, Serkan Tapan, Muammer Kara, Cemal Nuri Ercin, Fatih Aslan, Murat Kantarcioglu, Yildirim Karslioglu, Erdim Sertoglu, Mehmet Kemal Erbil & Sait Bagci. (2011) Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scandinavian Journal of Gastroenterology 46:11, pages 1355-1361.
Read now
Read now
Yusuf Yilmaz, Oya Yonal, Ramazan Kurt, Yesim Ozen Alahdab, Fatih Eren, Osman Ozdogan, Cigdem Ataizi Celikel, Nese Imeryuz, Cem Kalayci & Erol Avsar. (2011) Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 46:1, pages 91-97.
Read now
Read now
Leon A Adams & Ariel E Feldstein. (2010) Nonalcoholic steatohepatitis: risk factors and diagnosis. Expert Review of Gastroenterology & Hepatology 4:5, pages 623-635.
Read now
Read now
Teoman Dogru, Nuri Karadurmus, Serkan Tapan & Halil Genc. (2010) Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 45:7-8, pages 1000-1002.
Read now
Read now
Articles from other publishers (72)
Mohsen Rastkar, Leila Nikniaz, Mahdieh Abbasalizad Farhangi & Zeinab Nikniaz. (2023) Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Journal of Diabetes & Metabolic Disorders 22:1, pages 83-95.
Crossref
Crossref
Canbin Zheng, Yongping Zheng, Xi Chen, Xianyang Zhong, Xiaobin Zheng, Shuhui Yang & Zihui Zheng. (2023) α-NETA down-regulates CMKLR1 mRNA expression in ileum and prevents body weight gains collaborating with ERK inhibitor PD98059 in turn to alleviate hepatic steatosis in HFD-induced obese mice but no impact on ileal mucosal integrity and steatohepatitis progression. BMC Endocrine Disorders 23:1.
Crossref
Crossref
Yuqing Zhu, Yani Ke, Yijie Hu, Kaihan Wu, Shan Liu & Jie Hu. (2022) Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 21:1.
Crossref
Crossref
Qian Ren, Hongya Wang, Yan Zeng, Xia Fang, Mei Wang, Dongze Li, Wei Huang & Yong Xu. (2022) Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 21:1.
Crossref
Crossref
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali & Archana Burman. (2022) Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 123:10, pages 1553-1584.
Crossref
Crossref
Tobias F. Fischer & Annette G. Beck-Sickinger. (2022) Chemerin – exploring a versatile adipokine. Biological Chemistry 403:7, pages 625-642.
Crossref
Crossref
Josh Bilson, Jaswinder K. Sethi & Christopher D. Byrne. (2021) Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of the Nutrition Society 81:2, pages 146-161.
Crossref
Crossref
Simona Alexandra Iacob & Diana Gabriela Iacob. (2022) Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 13.
Crossref
Crossref
Alina Abdolahi, Zakaria Vahabzadeh, Esmael Izadpanah & Mohammad Raman Moloudi. (2022) Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway. Journal of Physiology and Biochemistry 78:1, pages 185-197.
Crossref
Crossref
Esra Akyüz Özkan, Allahverdi Sadigov & Osman Öztürk. (2022) Evaluation of Serum Omentin-1, Vaspin, Leptin, Adiponectin Levels in Obese/Overweight Children and Their Relationship With Non-Alcoholic Fatty Liver Disease. Clinical Nutrition Research 11:3, pages 194.
Crossref
Crossref
Michał Kukla, Tomasz Menżyk, Marcin Dembiński, Marek Winiarski, Aleksander Garlicki, Monika Bociąga-Jasik, Magdalena Skonieczna, Dorota Hudy, Barbara Maziarz, Beata Kusnierz-Cabala, Lubomir Skladany, Ivica Grgurevic, Małgorzata Wójcik-Bugajska, Tomasz Grodzicki, Dominika Stygar & Tomasz Rogula. (2021) Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes. Scientific Reports 11:1.
Crossref
Crossref
Delia Bogdanet, Catriona Reddin, Dearbhla Murphy, Helen C. Doheny, Jose A. Halperin, Fidelma Dunne & Paula M. O’Shea. (2021) Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review. Journal of Clinical Medicine 10:7, pages 1533.
Crossref
Crossref
Ozlem Kucukoglu, Jan-Peter Sowa, Guillermo Daniel Mazzolini, Wing-Kin Syn & Ali Canbay. (2021) Hepatokines and adipokines in NASH-related hepatocellular carcinoma. Journal of Hepatology 74:2, pages 442-457.
Crossref
Crossref
Damian Jacenik & Jakub Fichna. (2020) Chemerin in immune response and gastrointestinal pathophysiology. Clinica Chimica Acta 504, pages 146-153.
Crossref
Crossref
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk & Krzysztof Simon. (2020) Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLOS ONE 15:1, pages e0227459.
Crossref
Crossref
Lutfu Askin, Okan Tanriverdi, Hakan Tibilli & Serdar Turkmen. (2020) Associations between Vaspin Levels and Coronary Artery Disease. Cardiovascular Innovations and Applications 4:3.
Crossref
Crossref
Azimeh Izadi, Fereshteh Aliasghari, Bahram Pourghassem Gargari & Sara Ebrahimi. (2020) Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients. International Journal for Vitamin and Nutrition Research 90:1-2, pages 59-66.
Crossref
Crossref
David J. Ferland, Emma D. Flood, Hannah Garver, Steve T. Yeh, Stanley Riney, Adam E. Mullick, Gregory D. Fink & Stephanie W. Watts. (2019) Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions. Physiological Genomics 51:11, pages 553-561.
Crossref
Crossref
Jie Shi, Jiangao Fan, Qing Su & Zhen Yang. (2019) Cytokines and Abnormal Glucose and Lipid Metabolism. Frontiers in Endocrinology 10.
Crossref
Crossref
Susanne Feder, Arne Kandulski, Doris Schacherer, Thomas S. Weiss & Christa Buechler. (2019) Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. International Journal of Molecular Sciences 20:16, pages 3919.
Crossref
Crossref
Christa Buechler, Susanne Feder, Elisabeth Haberl & Charalampos Aslanidis. (2019) Chemerin Isoforms and Activity in Obesity. International Journal of Molecular Sciences 20:5, pages 1128.
Crossref
Crossref
Shawkey Ali, Doha Ellakwa, Sally Emara & Noha El-Sabbagh. (2018) The role of chemerin and vaspin in Egyptian patients with viral hepatitis C. Meta Gene 18, pages 23-30.
Crossref
Crossref
Stephanie W. Watts, Emma S. Darios, Adam E. Mullick, Hannah Garver, Thomas L. Saunders, Elizabeth D. Hughes, Wanda E. Filipiak, Michael G. Zeidler, Nichole McMullen, Christopher J. Sinal, Ramya K. Kumar, David J. Ferland & Gregory D. Fink. (2018) The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension. The FASEB Journal 32:12, pages 6596-6614.
Crossref
Crossref
Raghdaa Al Zarzour, Mohammed Alshawsh, Muhammad Asif, Majed Al-Mansoub, Zahurin Mohamed, Mariam Ahmad, Amin Abdul Majid, Mohd. Asmawi, Gurjeet Kaur, Dhamraa Al-dualimi & Mun Yam. (2018) Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease. Nutrients 10:8, pages 1057.
Crossref
Crossref
Sara Ebrahimi, Bahram Pourghassem Gargari, Azimeh Izadi, Bahareh Imani & Foad Asjodi. (2018) The effects of Ramadan fasting on serum concentrations of vaspin and omentin-1 in patients with nonalcoholic fatty liver disease. European Journal of Integrative Medicine 19, pages 110-114.
Crossref
Crossref
Chrysoula BoutariNikolaos PerakakisChristos Socrates Mantzoros. (2018) Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism 33:1, pages 33.
Crossref
Crossref
Leay-Kiaw Er, Semon Wu, Lung-An Hsu, Ming-Sheng Teng, Yu-Ching Sun & Yu-Lin Ko. (2018)
Pleiotropic Associations of
RARRES2
Gene Variants and Circulating Chemerin Levels: Potential Roles of Chemerin Involved in the Metabolic and Inflammation-Related Diseases
. Mediators of Inflammation 2018, pages 1-13.
Crossref
Crossref
Timon Adolph, Christoph Grander, Felix Grabherr & Herbert Tilg. (2017) Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. International Journal of Molecular Sciences 18:8, pages 1649.
Crossref
Crossref
Anat Yaskolka Meir, Lilac Tene, Noa Cohen, Ilan Shelef, Dan Schwarzfuchs, Yftach Gepner, Hila Zelicha, Michal Rein, Nitzan Bril, Dana Serfaty, Shira Kenigsbuch, Yoash Chassidim, Benjamin Sarusy, Dror Dicker, Joachim Thiery, Uta Ceglarek, Michael Stumvoll, Matthias Blüher, Meir J. Stampfer, Assaf Rudich & Iris Shai. (2017) Intrahepatic fat, abdominal adipose tissues, and metabolic state: magnetic resonance imaging study. Diabetes/Metabolism Research and Reviews 33:5, pages e2888.
Crossref
Crossref
Michał Kukla, Marek Waluga, Michał Żorniak, Agnieszka Berdowska, Piotr Wosiewicz, Tomasz Sawczyn, Rafał J Bułdak, Marek Ochman, Katarzyna Ziora, Tadeusz Krzemiński & Marek Hartleb. (2017) Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World Journal of Gastroenterology 23:14, pages 2613.
Crossref
Crossref
Rebekka Pohl, Elisabeth M. Haberl, Lisa Rein-Fischboeck, Sebastian Zimny, Maximilian Neumann, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Kristina Eisinger, Thomas S. Weiss & Christa Buechler. (2017) Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. European Journal of Clinical Investigation 47:1, pages 7-18.
Crossref
Crossref
Kyoung-Jin Oh, Da Lee, Won Kim, Baek Han, Sang Lee & Kwang-Hee Bae. (2016) Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines. International Journal of Molecular Sciences 18:1, pages 8.
Crossref
Crossref
Rasha T. Hamza, Zeinab A. Elkabbany, Ahmed M. Shedid, Amira I. Hamed & Asmaa O. Ebrahim. (2016) Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. Archives of Medical Research 47:7, pages 541-549.
Crossref
Crossref
Stergios A. Polyzos, Jannis Kountouras & Christos S. Mantzoros. (2016) Adipokines in nonalcoholic fatty liver disease. Metabolism 65:8, pages 1062-1079.
Crossref
Crossref
M. Bekaert, X. Verhelst, A. Geerts, B. Lapauw & P. Calders. (2015) Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic review. Obesity Reviews 17:1, pages 68-80.
Crossref
Crossref
Mélodie Diot, Maxime Reverchon, Christelle Rame, Pascal Froment, Jean-Pierre Brillard, Sylvain Brière, Gérard Levêque, Daniel Guillaume & Joëlle Dupont. (2015) Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys. Reproductive Biology and Endocrinology 13:1.
Crossref
Crossref
Salih BogaHuseyin AlkimAli Riza KoksalMehmet BayramMuveddet Banu Yilmaz OzguvenMeltem ErgunSebnem Tekin NeijmannGulay OzgonCanan Alkim. (2023) Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation with Insulin Resistance, Inflammation, and Liver Histology. Journal of Investigative Medicine 63:7, pages 871-877.
Crossref
Crossref
David J. Ferland & Stephanie W. Watts. (2015) Chemerin: A comprehensive review elucidating the need for cardiovascular research. Pharmacological Research 99, pages 351-361.
Crossref
Crossref
Ping Gu, Maowei Cheng, Xiaoyan Hui, Bin Lu, Weimin Jiang & Zhaorong Shi. (2015) Elevating circulation chemerin level is associated with endothelial dysfunction and early atherosclerotic changes in essential hypertensive patients. Journal of Hypertension 33:8, pages 1624-1632.
Crossref
Crossref
Erifili Hatziagelaki, Christian Herder, Anastasia Tsiavou, Tom Teichert, Athina Chounta, Peter Nowotny, Giovanni Pacini, George Dimitriadis & Michael Roden. (2015) Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD). PLOS ONE 10:5, pages e0124935.
Crossref
Crossref
Kristina Eisinger, Sabrina Krautbauer, Reiner Wiest, Thomas S. Weiss & Christa Buechler. (2015) Reduced serum chemerin in patients with more severe liver cirrhosis. Experimental and Molecular Pathology 98:2, pages 208-213.
Crossref
Crossref
M G M Wolfs, N Gruben, S S Rensen, F J Verdam, J W Greve, A Driessen, C Wijmenga, W A Buurman, L Franke, L Scheja, D P Y Koonen, R Shiri-Sverdlov, T W van Haeften, M H Hofker & J Fu. (2015) Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. Nutrition & Diabetes 5:2, pages e146-e146.
Crossref
Crossref
Gülsüm Özlem Elpek. (2015) Angiogenesis and liver fibrosis. World Journal of Hepatology 7:3, pages 377.
Crossref
Crossref
Jing He, Ji-Chun Li, Hua Xie, Zhong-Hua Xu, Ya-Wen Sun & Qiao Shan. (2015) Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Disease Markers 2015, pages 1-6.
Crossref
Crossref
Monika Kłusek-Oksiuta, Irena Bialokoz-Kalinowska, Eugeniusz Tarasów, Malgorzata Wojtkowska, Irena Werpachowska & Dariusz Marek Lebensztejn. (2014) Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children. Italian Journal of Pediatrics 40:1.
Crossref
Crossref
Mahdieh Abbasalizad Farhangi, Beytollah Alipour, Elnaz Jafarvand & Manouchehr Khoshbaten. (2014) Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress. Archives of Medical Research 45:7, pages 589-595.
Crossref
Crossref
Kenji Imai, Koji Takai, Tatsunori Hanai, Makoto Shiraki, Yusuke Suzuki, Hideki Hayashi, Takafumi Naiki, Youichi Nishigaki, Eiichi Tomita, Masahito Shimizu & Hisataka Moriwaki. (2014) Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences 15:7, pages 11294-11306.
Crossref
Crossref
Nanda Gruben, Marcela Aparicio Vergara, Niels J. Kloosterhuis, Henk van der Molen, Stefan Stoelwinder, Sameh Youssef, Alain de Bruin, Dianne J. Delsing, Jan Albert Kuivenhoven, Bart van de Sluis, Marten H. Hofker & Debby P. Y. Koonen. (2014) Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice. PLoS ONE 9:4, pages e96345.
Crossref
Crossref
Zi Ye, Suijun Wang, Zhen Yang, Min He, Shuo Zhang, Weiwei Zhang, Jie Wen, Qin Li, Ying Huang, Xuanchun Wang, Bin Lu, Zhaoyun Zhang, Qing Su & Renming Hu. (2014) Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Molecular Biology Reports 41:3, pages 1317-1323.
Crossref
Crossref
Stergios A. Polyzos, Jannis Kountouras, Athanasios D. Anastasilakis, Eleni V. Geladari & Christos S. Mantzoros. (2014) Irisin in patients with nonalcoholic fatty liver disease. Metabolism 63:2, pages 207-217.
Crossref
Crossref
Michał Kukla, Brygida Adamek, Marek Waluga, Marzena Zalewska-Ziob, Janusz Kasperczyk, Andrzej Gabriel, Włodzimierz Mazur, Barbara Sobala-Szczygieł, Rafał J. Bułdak, Wojciech Zajęcki, Lucjan Kępa, Katarzyna Ziora, Krystyna Żwirska-Korczala, Andrzej Wiczkowski & Marek Hartleb. (2014)
Hepatic
Chemerin
and
Chemokine-Like Receptor 1
Expression in Patients with Chronic Hepatitis C
. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
Ancha Baranova, Aybike Birerdinc & Zobair M. Younossi. 2014. Adipose Tissue and Adipokines in Health and Disease. Adipose Tissue and Adipokines in Health and Disease
249
283
.
S Döcke, J F Lock, A L Birkenfeld, S Hoppe, S Lieske, A Rieger, N Raschzok, I M Sauer, S Florian, M A Osterhoff, R Heller, K Herrmann, S Lindenmüller, P Horn, M Bauer, M O Weickert, P Neuhaus, M Stockmann, M Möhlig, A F H Pfeiffer & C von Loeffelholz. (2013) Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology 169:5, pages 547-557.
Crossref
Crossref
Sabrina Krautbauer, Josef Wanninger, Kristina Eisinger, Yvonne Hader, Michael Beck, Andrea Kopp, Andreas Schmid, Thomas S. Weiss, Christoph Dorn & Christa Buechler. (2013) Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Experimental and Molecular Pathology 95:2, pages 199-205.
Crossref
Crossref
Stephanie W. WattsAnne M. DorranceMark E. PenfoldJillian L. RourkeChristopher J. SinalBridget SeitzTimothy J. SullivanTrevor T. CharvatJanice M. ThompsonRobert BurnettGregory D. Fink. (2013) Chemerin Connects Fat to Arterial Contraction. Arteriosclerosis, Thrombosis, and Vascular Biology 33:6, pages 1320-1328.
Crossref
Crossref
Yujie Deng, Hui Wang, Yan Lu, Shuang Liu, Qiang Zhang, Jian Huang, Rongfeng Zhu, Jian Yang, Rong Zhang, Di Zhang, Weili Shen, Guang Ning & Ying Yang. (2013) Identification of Chemerin as a Novel FXR Target Gene Down-Regulated in the Progression of Nonalcoholic Steatohepatitis. Endocrinology 154:5, pages 1794-1801.
Crossref
Crossref
Michał Kukla. (2012) Angiogenesis: a phenomenon which aggravates chronic liver disease progression. Hepatology International 7:1, pages 4-12.
Crossref
Crossref
Ewa Stelmanska, Tomasz Sledzinski, Jacek Turyn, Malgorzata Presler, Justyna Korczynska & Julian Swierczynski. (2013) Chemerin gene expression is regulated by food restriction and food restriction–refeeding in rat adipose tissue but not in liver. Regulatory Peptides 181, pages 22-29.
Crossref
Crossref
Shali Mazaki-Tovi, Michal Kasher-Meron, Rina Hemi, Jigal Haas, Itai Gat, Daniel Lantsberg, Israel Hendler & Hannah Kanety. (2012) Chemerin is present in human cord blood and is positively correlated with birthweight. American Journal of Obstetrics and Gynecology 207:5, pages 412.e1-412.e10.
Crossref
Crossref
Y. Suzuki, Y. H. Hong, S. H. Song, A. Ardiyanti, D. Kato, K. H. So, K. Katoh & S. G. Roh. (2012) The Regulation of Chemerin and CMKLR1 Genes Expression by TNF-慣, Adiponectin, and Chemerin Analog in Bovine Differentiated Adipocytes. Asian-Australasian Journal of Animal Sciences 25:9, pages 1316-1321.
Crossref
Crossref
Anil Arora & Praveen Sharma. (2012) Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2:2, pages 145-155.
Crossref
Crossref
Krystian Adrych, Magdalena Stojek, Marian Smoczynski, Tomasz Sledzinski, Szrok-Wojtkiewicz Sylwia & Julian Swierczynski. (2012) Increased serum chemerin concentration in patients with chronic pancreatitis. Digestive and Liver Disease 44:5, pages 393-397.
Crossref
Crossref
Wilson Salgado Júnior & Carla Barbosa Nonino-Borges. (2011) Clinical Predictors of Different Grades of Nonalcoholic Fatty Liver Disease. Obesity Surgery 22:2, pages 248-252.
Crossref
Crossref
Przemyslaw Rutkowski, Tomasz Sledzinski, Hanna Zielinska, Slawomir Lizakowski, Elzbieta Goyke, Sylwia Szrok-Wojtkiewicz, Julian Swierczynski & Bolesław Rutkowski. (2012) Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regulatory Peptides 173:1-3, pages 55-59.
Crossref
Crossref
Elizabeth M. Brunt, Brent A. Neuschwander-Tetri & Alastair D. Burt. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
293
359
.
Michał Kukla, Włodzimierz Mazur, Rafał J. Bułdak & Krystyna Żwirska-Korczala. (2011) Potential Role of Leptin, Adiponectin and Three Novel Adipokines—Visfatin, Chemerin and Vaspin—in Chronic Hepatitis. Molecular Medicine 17:11-12, pages 1397-1410.
Crossref
Crossref
Maurizio ParolaFabio Marra. (2011) Adipokines and Redox Signaling: Impact on Fatty Liver Disease. Antioxidants & Redox Signaling 15:2, pages 461-483.
Crossref
Crossref
Yusuf Yilmaz, Ramazan Kurt, Ahmet Gurdal, Yesim Ozen Alahdab, Oya Yonal, Ebubekir Senates, Nihat Polat, Fatih Eren, Nese Imeryuz & Huseyin Oflaz. (2011) Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 217:1, pages 125-129.
Crossref
Crossref
Amir J. Guri & Josep Bassaganya‐Riera. (2012) Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation. Obesity 19:4, pages 689-700.
Crossref
Crossref
Bilge Aktas, Yusuf Yilmaz, Fatih Eren, Oya Yonal, Ramazan Kurt, Yesim Ozen Alahdab, Cigdem Ataizi Celikel, Osman Ozdogan, Nese Imeryuz, Cem Kalayci & Erol Avsar. (2011) Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism 60:4, pages 544-549.
Crossref
Crossref
Ji Young KimEun Sung KimJustin Y. JeonYoonsuk Jekal. (2011) Improved Insulin Resistance, Adiponectin and Liver Enzymes without Change in Plasma Vaspin Level after 12 Weeks of Exercise Training among Obese Male Adolescents. The Korean Journal of Obesity 20:3, pages 138.
Crossref
Crossref
David E. Amacher. (2011) Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies. Toxicology 279:1-3, pages 10-18.
Crossref
Crossref